Table 1. Type of participants, outcomes and follow-up periods reported.

Trials	Type of participants	Outcomes reported	Follow up periods
Knopf1999 [7]	Stable CAD	Any complication, MACEs	30 days
Carere2000 [5]	Stable CAD and ACS	Any complication, MACEs	30 days
Bertrand2008 [8]	Stable CAD and ACS	Death, MI, revascularization, major bleeding, transfusion, repeated hospitalization	30 days
Clavijio2016 [9]	Stable CAD and ACS	MACEs, major bleeding, recurrent hospitalization, mortality	30 days
Falcone2011 [10]	Stable CAD	Any adverse event	30 days
Heyde2007 [11]	Stable CAD	MACCE, death, MI, stroke, revascularization	24 hours
Kim2013 [12]	Stable CAD	MI, bleeding, hospitalization	30 days
Slagboom2005 [13]	Stable CAD and unstable angina (only type A and B)	Death, MI, revascularization, adverse events, bleeding, transfusion	30 days

Abbreviations: MI: myocardial infarction, MACEs: major adverse cardiac events, MACCEs: major adverse cardiovascular and cerebrovascular events, CAD: coronary artery disease, ACS: acute coronary syndrome